Caelus Health

Caelus Health is an Amsterdam-based biotech company with in-depth knowledge of the microbiome, dedicated to the development and commercialization of microbiota-based products to prevent and treat cardiometabolic disorders, including Diabetes, and other unmet medical needs. The company has built a strong patented-protected proprietary position for the treatment of Diabetes Mellitus Type 1 and Type 2, cancer cachexia and auto-immune diseases. Caelus Health builds on the experience of leading scientists in this field and is one of the very few companies that can effectively capture the value of Microbiome Therapeutics through their solid preclinical and early-stage clinical development approaches. Advancing Microbiome-Based Therapeutics through gut-microbiota based products & interventions.